Effects of 24-h Transdermal Delivery of Rotigotine on the Core Symptoms and Symptom Impact of Restless Legs Syndrome/Willis-Ekbom Disease: A Post Hoc Analysis of IRLS Single Item Data from a 6-Month Placebo-Controlled European Study (P04.037)

Authors :: Frank Grieger
Kimberly Moran
Ralf Kohnen
Elisabeth Dohin
Diego Garcia-Borreguero
Richard P. Allen
David B. Rye
Source :: Neurology. 78:P04.037-P04.037
Publication Year :: 2012
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2012.

Subjects :: medicine.medical_specialty
business.industry
Rotigotine
Placebo
medicine.disease
Single item
Post-hoc analysis
Physical therapy
Medicine
Willis-Ekbom disease
Neurology (clinical)
Restless legs syndrome
Core symptoms
business
medicine.drug
Transdermal

Full Text Access

Tools